Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
983 studies found for:    vaccines [CONDITION] OR vaccines [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
21 Not yet recruiting Adjuvanted Influenza Vaccine in Stem Cell Transplant
Conditions: Transplantation;   Influenza Vaccines
Interventions: Biological: FLUAD® influenza vaccine;   Biological: FLUVIRAL®
22 Unknown  Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.
Condition: Measles Vaccine
Intervention: Biological: Early measles vaccine
23 Recruiting Dendritic Cell Vaccine For Malignant Glioma and Glioblastoma Multiforme in Adult and Pediatric Subjects
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   High Grade Glioma
Interventions: Biological: Dendritic Cell Vaccine;   Biological: Tumor Lysate;   Other: Imiquimod;   Procedure: Leukapheresis
24 Unknown  Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients
Conditions: Serology Analysis;   Novel H1N1 Influenza Vaccination;   Pediatric Haemato-oncology Patients
Intervention: Biological: Influenza A (H1N1) 2009 monovalent vaccine, inactivated
25 Unknown  Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine
Condition: Malaria
Interventions: Biological: GMZ2 (malaria vaccine);   Biological: GMZ2 malaria vaccine;   Biological: Verorab vaccine
26 Recruiting Adolescent Vaccination in Pharmacies
Conditions: Evaluating Attitudes Toward HPV Vaccinations in Pharmacies;   Evaluating the Provision of HPV Vaccines in a Pharmacy
Intervention: Drug: HPV vaccine
27 Recruiting Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients.
Conditions: Malignant Melanoma;   Adjuvant Drug Therapy;   Vaccin Therapy
Intervention: Biological: Autologous Dendritic Cell vaccine
28 Recruiting A Safety and Immunogenicity Trial of IHV01
Condition: HIV Infection
Interventions: Biological: 0.25 mL FLSC Vaccine Group;   Biological: 0.25 mL Placebo Group;   Biological: 0.5 mL FLSC Vaccine Group;   Biological: 0.5 mL Placebo Group;   Biological: 1.0 mL FLSC Vaccine Group;   Biological: 1.0 mL Placebo Group
29 Recruiting Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)
Conditions: Yellow Fever Vaccine;   Immunity
Intervention: Biological: yellow fever vaccine
30 Recruiting Video to Promote HPV Vaccination
Conditions: Vaccine Acceptance;   Social Acceptance;   Acceptance Processes;   Health Behavior;   Human Papillomavirus
Intervention: Other: Educational Video with Male or Female Narrator
31 Not yet recruiting Safety Study of Enterovirus 71 Vaccine in Children Aged 6-35 Months Old
Condition: Enterovirus 71 Vaccine
Intervention: Biological: two doses enterovirus 71 vaccine
32 Recruiting Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma
Condition: Metastatic Melanoma
Interventions: Biological: DC vaccine;   Drug: Dasatinib
33 Recruiting Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
Conditions: HPV16+;   Cervical Intraepithelial Neoplasia (CIN 2/3)
Interventions: Biological: DNA vaccination;   Device: Gene gun vaccine;   Biological: intramuscular vaccination;   Biological: intra-lesional vaccine administration;   Procedure: therapeutic resection of the lesion;   Drug: imiquimod
34 Recruiting INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
Conditions: Heart Failure;   Myocardial Infarction
Interventions: Biological: High Dose Trivalent Influenza Vaccine;   Biological: Standard Dose Quadrivalent Influenza Vaccine
35 Recruiting The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age
Conditions: Mortality;   Vaccines
Intervention: Biological: Providing measles vaccine for all children 9-35 months who have not yet received a routine measles vaccine
36 Recruiting Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)
Conditions: Heart Failure;   Influenza
Interventions: Other: Sterile saline;   Drug: inactivated trivalent influenza vaccine
37 Not yet recruiting A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls
Condition: Human Papilloma Virus
Interventions: Drug: bivalent HPV vaccine;   Drug: nonavalent HPV vaccine
38 Recruiting Introduction of Cholera Vaccine in Bangladesh
Condition: Cholera
Interventions: Biological: ShanChol;   Behavioral: Vaccine and behaviour
39 Not yet recruiting Conjugate Vaccine Against Meningococcus C a Brazilian Project
Condition: Serogroup C Meningococcal Meningitis
Interventions: Biological: MenCC-BIO Vaccine;   Biological: Combined - CRM197
40 Recruiting Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors
Conditions: Glioma;   Brain Cancer;   Brain Tumor;   Glioblastoma Multiforme;   High Grade Glioma
Interventions: Biological: Dendritic Cell Vaccine;   Biological: Tumor Lysate;   Other: Imiquimod;   Procedure: Punch Biopsy of the Skin;   Procedure: Leukapheresis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years